Epitomee Medical Ltd (TLV:EPIT)
Israel · Delayed Price · Currency is ILS · Price in ILA 662.20
-5.20 (-0.78%)
At close: Dec 18, 2025
Epitomee Medical Company Description
Epitomee Medical Ltd, a biomedical company, develops and commercializes ingestible therapeutic devices worldwide.
It offers capsules, which are polymer-based scaffold for controlled delivery of therapies along the GI tract for weight management and biologics delivery.
The company was incorporated in 2005 and is based in Caesarea, Israel.
Epitomee Medical Ltd
| Country | Israel |
| Founded | 2005 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 42 |
| CEO | Radan Hashimshony |
Contact Details
Address: 17 Haturon St Caesarea, 3079892 Israel | |
| Phone | 972 7 4740 0799 |
| Website | epitomeemedical.com |
Stock Details
| Ticker Symbol | EPIT |
| Exchange | Tel Aviv Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| ISIN Number | IL0011825911 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Dr. Argil Cohen | Chief Executive Officer of Research & Development |
| Dr. Radan Hashimshony Ph.D. | Chief Executive Officer and General Secretary |
| Dr. Shimon Eckhouse Ph.D. | Co-Founder and Chairman of the Board |
| Gal Aharonowitz | Chief Operating Officer |
| Dr. Yael Kidan | Vice President of Clinical Affairs |
| Maya Gabrieli | Chief Financial Officer |
| Alon Heth | Vice President of Sales and Marketing |